fbpx

Partnership between Carl Zeiss and FYidoctors

Carl Zeiss Vision Canada and FYidoctors announce a partnership to produce ZEISS lenses.

Carl Zeiss Vision Canada authorized FYidoctors as the first non‐ZEISS lab to produce ZEISS lenses in Canada because of their commitment to outstanding customer service and their growing network of optometrists. The Eyence Lab will supply the FYidoctors network which includes over 280 locations and over 450 optometrists between its corporately owned and Vision Source Canada offices.

In addition to the ZEISS branded products, ZEISS has developed private label lens designs for the FYidoctors network and Vision Source Canada offices.

“FYidoctors and ZEISS share the goal of providing the best possible visual experience to their patients throughout Canada,” said John Dillon (President of Carl Zeiss Vision Canada). “We are proud to have them as a partner and distributor of our lenses.”

For further information: https://www.optiknow.ca/wp-content/uploads/2014/11/FYidoctors-NEWS-RELEASE1.pdf

New postoperative implant is effective

The first ever tear duct implant developed to treat inflammation and pain following cataract surgery could be a good alternative to eye drops.

The device automatically delivers the correct level of postoperative medication in patients. After 30 days, it liquefies and is evacuated through the tear ducts, without the need for outside intervention.

Tested in four American ophthalmology practices, the device delivered dexamethasone into the eyes of 30 patients over 30 days, while 30 other patients received a placebo. On day one, the placebo group reported pain three times higher than the medicated group. After 14 days, the pain was 11 times higher than it was for the others.

For further information: http://www.newswise.com/articles/tear-duct-implant-effective-at-reducing-pain-and-inflammation-in-cataract-surgery-patients

Google Glass device may reduce peripheral vision

A test conducted by researchers at the University of California, San Francisco, shows that the Google Glass device creates a blind spot in the wearer’s peripheral vision.

The researchers tested three wearers. They compared their findings to tests using the Google Glass, then with ordinary glasses of similar colour and similar temples.

The results of all three participants show that the device creates a blind spot, causing a significant visual obstruction in the upper right quadrant.

Also, analysis of the photos of 132 wearers shows that people tend to place the Google Glass device near or above their pupillary axis, which can cause blind spots and interfere with vision.

For further information: http://jama.jamanetwork.com/article.aspx?articleid=1920958

No 3D for children under age six

A French agency recommends zero exposure to 3D movies and video games for children under six years of age, and limiting usage of these devices for kids under 13.

The Agence nationale de sécurité sanitaire de l’alimentation, de l’environnement et du travail (a French governmental agency dealing with sanitary safety in food, the environment and at work) advises that 3D technology does not allow the eyes to converge and accommodate at the same distance when perceiving depth and relief. Visualizing 3D images accelerates the onset of eye fatigue, in addition to causing symptoms ranging from peri-ocular pain, dry eyes or visual disorders, to headaches or poor concentration.

More severe symptoms related to the vergence-accommodation conflict of the eyes could develop in children under six, due to the immaturity of their visual system.

For further information: https://www.anses.fr/en/content/3d-technologies-and-eyesight-use-not-recommended-chidren-under-age-six-use-moderation-those

Brien Holden receives honour from AAO

Brien Holden, a well-known figure in the industry, has received the highest scientific honour in optometry from the American Academy of Optometry (AAO).

He was presented with an award at the annual AAO meeting, held in Denver, Colorado, November 12–16, 2014.

Established in 1958, the Charles F. Prentice Medal recognizes a career-long record of advancement of knowledge in vision science.

Brien Holden is a professor at the University of New South Wales (UNSW), Australia, and CEO of Brien Holden Vision Institute, a global leader in research and innovation .

For further information: http://brienholdenvision.org/media-centre/latest-news/984-optometry-s-highest-honour-for-brien-holden.html

 

Featured Posts

Managing anxious children optometry pre-testing

Pivot to Patience: Managing the Emotionally Elevated Child in Pre-Testing

Discover 5 EQ-based strategies for managing an anxious or emotionally elevated child during optometry pre-testing in 2026. Learn how to de-escalate and ensure accurate clinical data.

Learn More
Voila July-August Optik 2026 Centennial DILLI DALLI 7111

Dilli Dalli – Now Available in Canda

Now available in Canada, Dilli Dalli offers fit-focused eyewear for infants, toddlers and children, with SoftTouch, TR-90 and lightweight metal options designed to support pediatric dispensing.

Read more
AYA Optical logo and Carla DAngelo photo 2026

AYA Optical: Where Art Meets Eyewear

AYA Optical brings together Indigenous art and contemporary eyewear design, creating frames that honour artists while offering a distinctive and meaningful visual identity.

Read more
The Vision Council Foundation logo

The Vision Council Foundation Expands “See What Matters” with New Back‑to‑School Eye Health Toolkit

The Vision Council Foundation has expanded its See What Matters initiative with new back to school toolkits focused on childhood myopia, digital eye strain and the importance of annual eye exams.

Read more
Bausch + Lomb

Bausch + Lomb Advances Two First‑in‑Class Eye Health Therapies Following New Clinical Results

Bausch + Lomb is advancing two first in class therapies following new clinical results, including a Phase 3 dry eye combination treatment and a TRPV1 antagonist showing early pain reduction.

Read more
Managing anxious children optometry pre-testing

Pivot to Patience: Managing the Emotionally Elevated Child in Pre-Testing

Discover 5 EQ-based strategies for managing an anxious or emotionally elevated child during optometry pre-testing in 2026. Learn how to de-escalate and ensure accurate clinical data.

Learn More
Voila July-August Optik 2026 Centennial DILLI DALLI 7111

Dilli Dalli – Now Available in Canda

Now available in Canada, Dilli Dalli offers fit-focused eyewear for infants, toddlers and children, with SoftTouch, TR-90 and lightweight metal options designed to support pediatric dispensing.

Read More
AYA Optical logo and Carla DAngelo photo 2026

AYA Optical: Where Art Meets Eyewear

AYA Optical brings together Indigenous art and contemporary eyewear design, creating frames that honour artists while offering a distinctive and meaningful visual identity.

Read More
The Vision Council Foundation logo

The Vision Council Foundation Expands “See What Matters” with New Back‑to‑School Eye Health Toolkit

The Vision Council Foundation has expanded its See What Matters initiative with new back to school toolkits focused on childhood myopia, digital eye strain and the importance of annual eye exams.

Read More
Bausch + Lomb

Bausch + Lomb Advances Two First‑in‑Class Eye Health Therapies Following New Clinical Results

Bausch + Lomb is advancing two first in class therapies following new clinical results, including a Phase 3 dry eye combination treatment and a TRPV1 antagonist showing early pain reduction.

Read More
Managing anxious children optometry pre-testing

Pivot to Patience: Managing the Emotionally Elevated Child in Pre-Testing

Discover 5 EQ-based strategies for managing an anxious or emotionally elevated child during optometry pre-testing in 2026. Learn how to de-escalate and ensure accurate clinical data.

Learn More
Voila July-August Optik 2026 Centennial DILLI DALLI 7111

Dilli Dalli – Now Available in Canda

Now available in Canada, Dilli Dalli offers fit-focused eyewear for infants, toddlers and children, with SoftTouch, TR-90 and lightweight metal options designed to support pediatric dispensing.

Read more
AYA Optical logo and Carla DAngelo photo 2026

AYA Optical: Where Art Meets Eyewear

AYA Optical brings together Indigenous art and contemporary eyewear design, creating frames that honour artists while offering a distinctive and meaningful visual identity.

Read more
The Vision Council Foundation logo

The Vision Council Foundation Expands “See What Matters” with New Back‑to‑School Eye Health Toolkit

The Vision Council Foundation has expanded its See What Matters initiative with new back to school toolkits focused on childhood myopia, digital eye strain and the importance of annual eye exams.

Read more
Bausch + Lomb

Bausch + Lomb Advances Two First‑in‑Class Eye Health Therapies Following New Clinical Results

Bausch + Lomb is advancing two first in class therapies following new clinical results, including a Phase 3 dry eye combination treatment and a TRPV1 antagonist showing early pain reduction.

Read more
Managing anxious children optometry pre-testing

Pivot to Patience: Managing the Emotionally Elevated Child in Pre-Testing

Discover 5 EQ-based strategies for managing an anxious or emotionally elevated child during optometry pre-testing in 2026. Learn how to de-escalate and ensure accurate clinical data.

Learn More
Voila July-August Optik 2026 Centennial DILLI DALLI 7111

Dilli Dalli – Now Available in Canda

Now available in Canada, Dilli Dalli offers fit-focused eyewear for infants, toddlers and children, with SoftTouch, TR-90 and lightweight metal options designed to support pediatric dispensing.

Read more
AYA Optical logo and Carla DAngelo photo 2026

AYA Optical: Where Art Meets Eyewear

AYA Optical brings together Indigenous art and contemporary eyewear design, creating frames that honour artists while offering a distinctive and meaningful visual identity.

Read more
The Vision Council Foundation logo

The Vision Council Foundation Expands “See What Matters” with New Back‑to‑School Eye Health Toolkit

The Vision Council Foundation has expanded its See What Matters initiative with new back to school toolkits focused on childhood myopia, digital eye strain and the importance of annual eye exams.

Read more
Bausch + Lomb

Bausch + Lomb Advances Two First‑in‑Class Eye Health Therapies Following New Clinical Results

Bausch + Lomb is advancing two first in class therapies following new clinical results, including a Phase 3 dry eye combination treatment and a TRPV1 antagonist showing early pain reduction.

Read more